Ceramide: a Common Pathway for Atherosclerosis?

Overview

Journal Atherosclerosis

Publisher Elsevier

Specialty Cardiology & Vascular Diseases

Date 2007 Oct 30

PMID 17963772

Citations 76

Authors

Jean Bismuth

Peter Lin

Qizhi Yao

Changyi Chen

Affiliations

Soon will be listed here.

Abstract

Plasma sphingomyelin concentration is correlated with the development of atherosclerosis. It has been found to exist in significantly higher concentrations in aortic plaque. This appears to have clinical relevance as well as it has been shown to be an independent predictor of coronary artery disease. Ceramide, the backbone of sphingolipids, is the key component which affects atherosclerotic changes through its important second-messenger role. This paper sheds light on some of the current literature supporting the significance of ceramide with respect to its interactions with lipids, inflammatory cytokines, homocysteine and matrix metalloproteinases. Furthermore, the potential therapeutic implications of modulating ceramide concentrations are also discussed.

Citing Articles

Metabolomics-Based Machine Learning for Predicting Mortality: Unveiling Multisystem Impacts on Health.

Oravilahti A, Vangipurapu J, Laakso M, Fernandes Silva L Int J Mol Sci. 2024; 25(21).

PMID: 39519188 PMC: 11546733. DOI: 10.3390/ijms252111636.

Adiponectin overexpression improves metabolic abnormalities caused by acid ceramidase deficiency but does not prolong lifespan in a mouse model of Farber Disease.

Norris M, Tippetts T, Wilkerson J, Nicholson R, Maschek J, Levade T Mol Genet Metab Rep. 2024; 39:101077.

PMID: 38595987 PMC: 11002753. DOI: 10.1016/j.ymgmr.2024.101077.

Ceramides are fuel gauges on the drive to cardiometabolic disease.

Wilkerson J, Tatum S, Holland W, Summers S Physiol Rev. 2024; 104(3):1061-1119.

PMID: 38300524 PMC: 11381030. DOI: 10.1152/physrev.00008.2023.

Ceramides and metabolic profiles of patients with acute coronary disease: a cross-sectional study.

Zhang L, Tan D, Zhang Y, Ding Y, Liang H, Zhang G Front Physiol. 2023; 14:1177765.

PMID: 38146506 PMC: 10749667. DOI: 10.3389/fphys.2023.1177765.

Ceramides in peripheral arterial plaque lead to endothelial cell dysfunction.

Meade R, Chao Y, Harroun N, Li C, Hafezi S, Hsu F JVS Vasc Sci. 2023; 4:100181.

PMID: 38077163 PMC: 10704331. DOI: 10.1016/j.jvssci.2023.100181.

References

Bhunia A, Han H, Snowden A, Chatterjee S . Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J Biol Chem. 1997; 272(25):15642-9. DOI: 10.1074/jbc.272.25.15642. View

Prokazova N, Mukhin D, Orekhov A, Gladkaya E, Vasilevskaya V, Mikhailenko I . Neutral glycolipids of atherosclerotic plaques and unaffected human aorta tissue. Eur J Biochem. 1989; 180(1):167-71. DOI: 10.1111/j.1432-1033.1989.tb14628.x. View

Hurlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O . Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation. 2002; 106(17):2184-7. DOI: 10.1161/01.cir.0000037521.71373.44. View

Li J, Zheng X, Li J . Statins may be beneficial for patients with slow coronary flow syndrome due to its anti-inflammatory property. Med Hypotheses. 2007; 69(2):333-7. DOI: 10.1016/j.mehy.2006.09.070. View

Memon R, Bass N, MOSER A, Fuller J, Appel R, Grunfeld C . Down-regulation of liver and heart specific fatty acid binding proteins by endotoxin and cytokines in vivo. Biochim Biophys Acta. 1999; 1440(1):118-26. DOI: 10.1016/s1388-1981(99)00120-1. View

Nakamura M, Yoshida H, Arakawa N, Saitoh S, Satoh M, Hiramori K . Effects of tumor necrosis factor-alpha on basal and stimulated endothelium-dependent vasomotion in human resistance vessel. J Cardiovasc Pharmacol. 2000; 36(4):487-92. DOI: 10.1097/00005344-200010000-00011. View

Csiszar A, Labinskyy N, Smith K, Rivera A, Orosz Z, Ungvari Z . Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging. Am J Pathol. 2007; 170(1):388-98. PMC: 1762698. DOI: 10.2353/ajpath.2007.060708. View

Schissel S, Rapp J, Graham G, Williams K, Tabas I . Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J Clin Invest. 1996; 98(6):1455-64. PMC: 507573. DOI: 10.1172/JCI118934. View

Hojjati M, Li Z, Zhou H, Tang S, Huan C, Ooi E . Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice. J Biol Chem. 2004; 280(11):10284-9. DOI: 10.1074/jbc.M412348200. View

10.

Zhang D, Zou A, Li P . Ceramide reduces endothelium-dependent vasodilation by increasing superoxide production in small bovine coronary arteries. Circ Res. 2001; 88(8):824-31. DOI: 10.1161/hh0801.089604. View

11.

Rajavashisth T, Liao J, Galis Z, Tripathi S, Laufs U, Tripathi J . Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J Biol Chem. 1999; 274(17):11924-9. DOI: 10.1074/jbc.274.17.11924. View

12.

Yi F, Zhang A, Li N, Muh R, Fillet M, Renert A . Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats. Kidney Int. 2006; 70(1):88-96. DOI: 10.1038/sj.ki.5001517. View

13.

Shabahang S, Liu Y, Huwiler A, Pfeilschifter J . Identification of the LIM kinase-1 as a ceramide-regulated gene in renal mesangial cells. Biochem Biophys Res Commun. 2002; 298(3):408-13. DOI: 10.1016/s0006-291x(02)02483-x. View

14.

Igarashi J, Thatte H, Prabhakar P, Golan D, Michel T . Calcium-independent activation of endothelial nitric oxide synthase by ceramide. Proc Natl Acad Sci U S A. 1999; 96(22):12583-8. PMC: 22998. DOI: 10.1073/pnas.96.22.12583. View

15.

Fujita T, Inoue K, Yamamoto S, Ikumoto T, Sasaki S, Toyama R . Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite. J Antibiot (Tokyo). 1994; 47(2):208-15. DOI: 10.7164/antibiotics.47.208. View

16.

Karliner J, Honbo N, Summers K, Gray M, Goetzl E . The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J Mol Cell Cardiol. 2001; 33(9):1713-7. DOI: 10.1006/jmcc.2001.1429. View

17.

Olivera A, Kohama T, Edsall L, Nava V, Cuvillier O, Poulton S . Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol. 1999; 147(3):545-58. PMC: 2151183. DOI: 10.1083/jcb.147.3.545. View

18.

Chen S, Hu C, Yang D, Nassief A, Chen H, Yin K . Pravastatin attenuates ceramide-induced cytotoxicity in mouse cerebral endothelial cells with HIF-1 activation and VEGF upregulation. Ann N Y Acad Sci. 2005; 1042:357-64. DOI: 10.1196/annals.1338.033. View

19.

Xu X, Meisel S, Ong J, Kaul S, Cercek B, Rajavashisth T . Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation. 1999; 99(8):993-8. DOI: 10.1161/01.cir.99.8.993. View

20.

Zhang D, Fryer R, Hsu A, Zou A, Gross G, Campbell W . Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats. Basic Res Cardiol. 2001; 96(3):267-74. DOI: 10.1007/s003950170057. View